GLP-1 Coverage & Costs in California (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm California at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
California Medicaid Coverage for GLP-1
Medicaid: not covered as of January 2026 (KFF)
KFF's map lists California as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF says the state eliminated coverage after its October 2025 survey. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Your Options in California:
- Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves California
- Commercial or employer insurance: check your plan's drug list and prior authorization rules
- Medicare GLP-1 Bridge for eligible Part D enrollees (see below)
California Medicaid GLP-1 Prescriptions in 2025
3,089,327
#1
$3.41 billion
Wegovy
California Medicaid paid for 3,089,327 GLP-1 prescriptions in 2025, 27.4% of the 11.26 million paid nationally and number 1 of 51 (50 states and DC). It reimbursed pharmacies $3.41 billion before manufacturer rebates, about $1,103 per prescription, and the most-filled product was Wegovy. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 1,712,999 of those prescriptions (55.4%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, California Medicaid GLP-1 prescriptions went from 323,813 to 3,089,327, 9.5 times the 2021 count. From 2024 to 2025 the count rose by 1,178,474.
323,813
529,547
1,138,924
1,910,853
3,089,327
| Product | CA Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Wegovy | 1,000,304 | 32.4% |
| Ozempic | 915,084 | 29.6% |
| Zepbound | 701,827 | 22.7% |
| Mounjaro | 233,535 | 7.6% |
| Trulicity | 127,774 | 4.1% |
| Rybelsus | 85,505 | 2.8% |
| Saxenda | 10,868 | 0.4% |
| Liraglutide (generic) | 9,710 | 0.3% |
| Victoza | 3,862 | 0.1% |
| Bydureon | 816 | under 0.1% |
| Byetta | 31 | under 0.1% |
| Exenatide (generic) | 11 | under 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
California Employee Plan and Insurer GLP-1 Rules
CalPERS health program
Covers with limitsAll CalPERS health plans cover GLP-1s for diabetes and certain obesity-related conditions such as sleep apnea. CalPERS HMO plans that run their own pharmacy benefit, including Blue Shield of California and Kaiser Permanente, also cover them for morbid obesity (BMI of 40 or higher) with prior authorization.
CalPERS's June 2026 Board item says every CalPERS plan covers GLP-1s for diabetes and certain obesity-related conditions.
“All CalPERS health plans currently cover GLP-1 medications for diabetes and certain obesity-related conditions, including obstructive sleep apnea, cardiovascular risk factors, and Metabolic Dysfunction-Associated Steatohepatitis.”
Source: CalPERS Board of Administration. Read October 29, 2026.
Knox-Keene regulated CalPERS plans that manage their own pharmacy benefit cover GLP-1s for morbid obesity, with prior authorization.
“CalPERS’ Knox-Keene regulated plans that manage their own pharmacy benefit, including HMO plans offered by Blue Shield of California and Kaiser Permanente, cover GLP-1 medications for morbid obesity (BMI ≥ 40 kg/m2), subject to prior authorization requirements.”
Source: CalPERS Board of Administration. Read October 29, 2026.
Health plans regulated under California's Knox-Keene Act
Covers with limitsCalPERS states that California law requires Knox-Keene regulated health plans to cover GLP-1s for diabetes and for morbid obesity (BMI of 40 or higher).
The same CalPERS Board item describes the state coverage requirement for Knox-Keene plans.
“California law requires coverage of GLP-1 medications for diabetes and morbid obesity (BMI ≥ 40 kg/m2) in health plans regulated under the Knox-Keene Health Care Service Plan Act of 1975.”
Source: CalPERS Board of Administration. Read October 29, 2026.
Blue Shield of California
Covers with limitsFrom January 1, 2025 or plan renewal, Blue Shield of California stopped covering weight loss medications for some commercial PPO and HMO members unless they are medically necessary for Class III (morbid) obesity, with a required weight loss program.
Blue Shield of California's November 2024 fact sheet ends coverage of listed weight loss medications for some commercial members from January 1, 2025 or renewal, unless authorized as medically necessary.
“Beginning January 1, 2025, or upon an employer group’s or individual purchaser’s plan renewal after that date, the weight loss medications listed below will no longer be covered for some Blue Shield of California (Blue Shield) commercial PPO and HMO plan members unless authorization for medical necessity is provided by Blue Shield.”
Source: Blue Shield of California. Read October 29, 2026.
Authorization for affected members requires a current or previous Class III obesity diagnosis.
“Blue Shield will authorize weight loss medications for members affected by the benefit change if the medication is determined to be medically necessary for the treatment of a current or previous diagnosis of Class III (morbid) obesity.”
Source: Blue Shield of California. Read October 29, 2026.
Comparing self-pay programs in California?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for California
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for California. The rest record a state count without naming the states, so confirm California with the program at intake before you pay.
What Programs' Own Pages Say About California
8 of the 8 programs whose own pages name the states they serve include California: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | California |
|---|---|
| Willow | Serves CA |
| SnagRx | Serves CA |
| Strut Health | Ships to CA |
| MangoRx | Ships to CA |
| Wellorithm | Serves CA |
| MEDGm | Serves CA |
| TelosRx | Serves CA |
| Trimi | Serves CA |
Trimi's state table lists California as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for California is Cal. Bus. & Prof. Code 2242(a). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in California
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in California, 2024
California prescribers wrote 1,865,079 Medicare Part D GLP-1 claims in 2024, number 1 of 51, with $2.17 billion in gross drug cost before rebates. Ozempic led with 1,000,639 claims for 182,601 enrollees. Wegovy had 18,355 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | CA Part D claims | Enrollees |
|---|---|---|
| Ozempic | 1,000,639 | 182,601 |
| Trulicity | 323,595 | 60,742 |
| Mounjaro | 284,575 | 50,447 |
| Rybelsus | 157,307 | 39,219 |
| Victoza | 48,370 | Not given |
| Liraglutide | 20,860 | 8,197 |
| Wegovy | 18,355 | 4,721 |
| Bydureon Bcise | 10,695 | 2,248 |
| Byetta | 668 | 153 |
| Zepbound | 15 | 15 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in California
The Bridge is national, so the rules are the same in California as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How California Compares to Other West States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how California and its neighbors in the West are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| California (this page) | Not covered | 3,089,327 |
| Nevada | Not covered | 70,791 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
GLP-1 Guides for California Cities
If Your Insurance Denies GLP-1 Coverage in California
Commercial plans offer an internal appeal, then external review; California Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in California
- California Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: CalPERS health program, covers with limits per the documents cited above. Confirm with the plan before you fill a prescription.
- Insurers on record for California: Health plans regulated under California's Knox-Keene Act, Blue Shield of California. Each still depends on whether your employer bought the weight-loss benefit.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in California
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in California.
Frequently Asked Questions — California
Does California Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did California Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in California in 2024?
Does the California state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in California?
Which online GLP-1 programs serve California?
Does Medicare cover GLP-1s in California?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.